Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome

CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066

Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research